Sherwin-Williams (NYSE:SHW - Get Free Report)'s stock had its "buy" rating reissued by analysts at Argus in a research report issued on Wednesday, Benzinga reports. They presently have a $380.00 price objective on the specialty chemicals company's stock. Argus's price target indicates a potential upside of 10.63% from the company's current price.
Other equities analysts also recently issued research reports about the company. JPMorgan Chase & Co. dropped their price target on Sherwin-Williams from $380.00 to $375.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 28th. Deutsche Bank lifted their price objective on Sherwin-Williams from $355.00 to $375.00 and gave the company a "hold" rating in a report on Wednesday, July 29th. Guggenheim reaffirmed a "buy" rating and issued a $375.00 price objective (down from $400.00) on shares of Sherwin-Williams in a research note on Wednesday, October 28th. BMO Capital Markets reiterated an "outperform" rating on shares of Sherwin-Williams in a report on Monday, September 28th. Finally, Wells Fargo & Company set a $340.00 target price on shares of Sherwin-Williams and gave the stock an "equal weight" rating in a report on Friday, September 25th. Fifteen equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $378.33.
Read Our Latest Stock Report on SHW
Sherwin-Williams Trading Down 0.2%
SHW traded down $0.67 during trading on Wednesday, hitting $343.48. 236,691 shares of the stock were exchanged, compared to its average volume of 1,949,011. The firm has a 50 day simple moving average of $332.19 and a 200 day simple moving average of $333.07. The firm has a market cap of $82.98 billion, a price-to-earnings ratio of 31.48, a P/E/G ratio of 2.92 and a beta of 1.05. Sherwin-Williams has a 1 year low of $289.86 and a 1 year high of $377.77. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.45 and a current ratio of 0.71.
Sherwin-Williams (NYSE:SHW - Get Free Report) last issued its earnings results on Tuesday, October 27th. The specialty chemicals company reported $3.63 earnings per share for the quarter, missing analysts' consensus estimates of $3.69 by ($0.06). Sherwin-Williams had a net margin of 10.74% and a return on equity of 69.51%. The firm had revenue of $6.86 billion for the quarter, compared to the consensus estimate of $6.78 billion. During the same period last year, the firm earned $3.59 earnings per share. The company's revenue for the quarter was up 7.9% on a year-over-year basis. As a group, equities analysts expect that Sherwin-Williams will post 12.01 EPS for the current year.
Insider Activity
In related news, SVP James R. Jaye sold 2,301 shares of the business's stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $345.56, for a total transaction of $795,133.56. Following the completion of the transaction, the senior vice president owned 6,936 shares in the company, valued at $2,396,804.16. The trade was a 24.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO James P. Lang sold 1,309 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $361.91, for a total transaction of $473,740.19. Following the sale, the chief accounting officer directly owned 861 shares of the company's stock, valued at $311,604.51. The trade was a 60.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 8,815 shares of company stock worth $3,086,621. Insiders own 0.23% of the company's stock.
Institutional Trading of Sherwin-Williams
Hedge funds and other institutional investors have recently made changes to their positions in the business. Eastern Bank boosted its position in Sherwin-Williams by 50.8% during the second quarter. Eastern Bank now owns 89 shares of the specialty chemicals company's stock worth $31,000 after purchasing an additional 30 shares in the last quarter. Jacobi Capital Management LLC grew its holdings in Sherwin-Williams by 1.0% in the third quarter. Jacobi Capital Management LLC now owns 3,156 shares of the specialty chemicals company's stock valued at $1,020,000 after purchasing an additional 30 shares during the period. Focus Financial Network Inc. increased its position in shares of Sherwin-Williams by 1.0% in the third quarter. Focus Financial Network Inc. now owns 3,068 shares of the specialty chemicals company's stock valued at $992,000 after buying an additional 31 shares in the last quarter. Verdence Capital Advisors LLC increased its position in shares of Sherwin-Williams by 4.0% in the third quarter. Verdence Capital Advisors LLC now owns 812 shares of the specialty chemicals company's stock valued at $263,000 after buying an additional 31 shares in the last quarter. Finally, Bouchey Financial Group Ltd. increased its position in shares of Sherwin-Williams by 4.6% in the third quarter. Bouchey Financial Group Ltd. now owns 732 shares of the specialty chemicals company's stock valued at $237,000 after buying an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 77.67% of the company's stock.
Sherwin-Williams Company Profile
(
Get Free Report)
The Sherwin-Williams Company is a global manufacturer, retailer and distributor of paints and coatings. Founded in 1866 and headquartered in Cleveland, Ohio, the company serves customers through company-operated paint stores, home improvement retailers, distributors and other channels. Its products include paints, stains and related supplies for homes and commercial buildings, as well as coatings for industrial, automotive, protective and marine applications. The company markets products under brands including Sherwin-Williams and Valspar.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.